These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12957610)

  • 1. Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation--a distinct entity?
    Klingenberg R; Koch A; Schnabel PA; Zimmermann R; Sack FU; Haass M; Dengler TJ
    J Heart Lung Transplant; 2003 Sep; 22(9):1005-13. PubMed ID: 12957610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation.
    Brunner-La Rocca HP; Kiowski W
    Transplantation; 1998 Feb; 65(4):533-8. PubMed ID: 9500629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation.
    Gradek WQ; D'Amico C; Smith AL; Vega D; Book WM
    J Heart Lung Transplant; 2001 May; 20(5):497-502. PubMed ID: 11343975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation.
    Brunner-La Rocca HP; Sütsch G; Schneider J; Follath F; Kiowski W
    Circulation; 1996 Sep; 94(6):1334-8. PubMed ID: 8822989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
    Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
    J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited utility of endomyocardial biopsy in the first year after heart transplantation.
    Hamour IM; Burke MM; Bell AD; Panicker MG; Banerjee R; Banner NR
    Transplantation; 2008 Apr; 85(7):969-74. PubMed ID: 18408576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adopting a new histological grading system of acute rejection after heart transplantation.
    Balk AH; Zondervan PE; van der Meer P; van Gelder T; Mochtar B; Simoons ML; Weimar W
    Heart; 1997 Dec; 78(6):603-7. PubMed ID: 9470880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection.
    Park MH; Starling RC; Ratliff NB; McCarthy PM; Smedira NS; Pelegrin D; Young JB
    J Heart Lung Transplant; 1999 Dec; 18(12):1224-7. PubMed ID: 10612382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy.
    Athanassopoulos P; Vaessen LM; Balk AH; Takkenberg JJ; Maat AP; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2005 May; 27(5):783-9. PubMed ID: 15848314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
    Winters GL; Loh E; Schoen FJ
    Circulation; 1995 Apr; 91(7):1975-80. PubMed ID: 7895355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies).
    Wagner K; Oliver MC; Boyle GJ; Miller SA; Law YM; Pigula F; Webber SA
    Pediatr Transplant; 2000 Aug; 4(3):186-92. PubMed ID: 10933318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.
    Marboe CC; Billingham M; Eisen H; Deng MC; Baron H; Mehra M; Hunt S; Wohlgemuth J; Mahmood I; Prentice J; Berry G
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S219-26. PubMed ID: 15993777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].
    Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M
    Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.
    Eisen HJ; Hobbs RE; Davis SF; Laufer G; Mancini DM; Renlund DG; Valantine H; Ventura H; Vachiery JL; Bourge RC; Canver CC; Carrier M; Costanzo MR; Copeland J; Dureau G; Frazier OH; Dorent R; Hauptman PJ; Kells C; Master R; Michaud JL; Paradis I; Smith A; Vanhaecke J; Mueller EA
    Transplantation; 1999 Sep; 68(5):663-71. PubMed ID: 10507486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.
    Brunner-La Rocca HP; Schneider J; Künzli A; Turina M; Kiowski W
    Transplantation; 1998 Feb; 65(4):538-43. PubMed ID: 9500630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What else distinguishes cellular rejection grade 1A from 0? Annexin V and BCL in elective biopsies received from heart transplant recipients.
    Zeglen S; Nozynski J; Wozniak-Grygiel E; Zakliczynski M; Kucewicz-Czech E; Laszewska A; Cichoracka A; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3198-201. PubMed ID: 19857709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
    Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
    Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy.
    Felkel TO; Smith AL; Reichenspurner HC; LaFleur B; Lutz JF; Kanter KR; Gravanis MB; Johnston TS
    J Heart Lung Transplant; 2002 May; 21(5):530-9. PubMed ID: 11983542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-center retrospective clinicopathologic study of endomyocardial biopsies after heart transplant at Baskent University Hospital in Ankara, 1993-2014.
    Terzi A; Sezgin A; Tunca Z; Deniz E; Ayva EŞ; Haberal Reyhan N; Müderrisoğlu H; Özdemir BH
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():346-51. PubMed ID: 25894188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.